Latest filing published 27 Jan 2026 for MetaVia Inc..
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Marshall H. Woodworth discloses dealings in 2 companies, chiefly MetaVia Inc. and Furiex Pharmaceuticals, Inc. In total, 7 filings cover trades dated from 4 November 2011 to 23 January 2026.
The open-market record is one-sided, with 2 purchases worth €75k and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 4 share grants.
On 27 January 2026 came the latest disclosure, a share grant in MetaVia Inc. The latest purchase dates back some time: it was published 509 days ago, on 4 June 2025. Typically, a trade is published a median of 3 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations